Licensing agreements
The technology development body ITI Life Sciences, which is funded by the regional development agency Scottish Enterprise, has signed licensing agreements around intellectual property created under its fluorescence lifetime assay programme.
The first licence, with Almac Sciences Ltd, relates to novel fluorescent dyes and their uses. The second, with Edinburgh Instruments, relates to a fluorescence lifetime plate reader for use in high throughput screening.
Both licences are the fruit of an 18-month research programme, which was funded and managed by ITI Life Sciences, and carried out by the two companies.
Eleanor Mitchell, ITI Life Sciences’ acting CEO, said the licences will help accelerate the introduction of products into the fluorescence lifetime instrumentation market. ITI Life Sciences aims to license its IP for the maximum commercial and economic impact for Scotland, she said. “We are pleased that our research providers decided to undertake the commercialisation of these outputs of the programme.”
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
